These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 3003384)

  • 1. Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing.
    La Monica N; Meriam C; Racaniello VR
    J Virol; 1986 Feb; 57(2):515-25. PubMed ID: 3003384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: involvement of residues of polypeptides VP1 and VP2 located on the inner surface of the capsid protein shell.
    Couderc T; Hogle J; Le Blay H; Horaud F; Blondel B
    J Virol; 1993 Jul; 67(7):3808-17. PubMed ID: 8389907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse neurovirulence determinants of poliovirus type 1 strain LS-a map to the coding regions of capsid protein VP1 and proteinase 2Apro.
    Lu HH; Yang CF; Murdin AD; Klein MH; Harber JJ; Kew OM; Wimmer E
    J Virol; 1994 Nov; 68(11):7507-15. PubMed ID: 7933134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of attenuating sequences of an avirulent poliovirus type 2 strain.
    Moss EG; O'Neill RE; Racaniello VR
    J Virol; 1989 May; 63(5):1884-90. PubMed ID: 2539491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced mouse neurovirulence of poliovirus type 2 Lansing antigenic variants selected with monoclonal antibodies.
    La Monica N; Kupsky WJ; Racaniello VR
    Virology; 1987 Dec; 161(2):429-37. PubMed ID: 2825415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain.
    Kohara M; Omata T; Kameda A; Semler BL; Itoh H; Wimmer E; Nomoto A
    J Virol; 1985 Mar; 53(3):786-92. PubMed ID: 2983090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine.
    Bouchard MJ; Lam DH; Racaniello VR
    J Virol; 1995 Aug; 69(8):4972-8. PubMed ID: 7609067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of two determinants that attenuate vaccine-related type 2 poliovirus.
    Ren RB; Moss EG; Racaniello VR
    J Virol; 1991 Mar; 65(3):1377-82. PubMed ID: 1847458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a chimaeric type 1/type 2 poliovirus by genetic recombination.
    Martin A; Wychowski C; Benichou D; Crainic R; Girard M
    Ann Inst Pasteur Virol; 1988; 139(1):79-88. PubMed ID: 2849960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of the attenuation phenotype of poliovirus type 1.
    Omata T; Kohara M; Kuge S; Komatsu T; Abe S; Semler BL; Kameda A; Itoh H; Arita M; Wimmer E
    J Virol; 1986 May; 58(2):348-58. PubMed ID: 3009852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of genomic regions specific for the attenuated, mouse-adapted poliovirus type 2 strain W-2.
    Pevear DC; Oh CK; Cunningham LL; Calenoff M; Jubelt B
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():43-52. PubMed ID: 2154539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host range determinants located on the interior of the poliovirus capsid.
    Moss EG; Racaniello VR
    EMBO J; 1991 May; 10(5):1067-74. PubMed ID: 1850692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine.
    Westrop GD; Wareham KA; Evans DM; Dunn G; Minor PD; Magrath DI; Taffs F; Marsden S; Skinner MA; Schild GC
    J Virol; 1989 Mar; 63(3):1338-44. PubMed ID: 2536836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mouse neurovirulence of antigenic chimeras (type I/II) of polioviruses].
    Dai C
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Feb; 15(1):34-8. PubMed ID: 7686824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuated poliovirus strain as a live vector: expression of regions of rotavirus outer capsid protein VP7 by using recombinant Sabin 3 viruses.
    Mattion NM; Reilly PA; DiMichele SJ; Crowley JC; Weeks-Levy C
    J Virol; 1994 Jun; 68(6):3925-33. PubMed ID: 8189529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and properties of intertypic poliovirus recombinants: first approximation mapping of the major determinants of neurovirulence.
    Agol VI; Grachev VP; Drozdov SG; Kolesnikova MS; Kozlov VG; Ralph NM; Romanova LI; Tolskaya EA; Tyufanov AV; Viktorova EG
    Virology; 1984 Jul; 136(1):41-55. PubMed ID: 6330995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.
    Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
    J Virol; 1988 Aug; 62(8):2828-35. PubMed ID: 2839704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleic acid sequence of the region of the genome encoding capsid protein VP1 of neurovirulent and attenuated type 3 polioviruses.
    Stanway G; Cann AJ; Hauptmann R; Mountford RC; Clarke LD; Reeve P; Minor PD; Schild GC; Almond JW
    Eur J Biochem; 1983 Oct; 135(3):529-33. PubMed ID: 6311539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I.
    Murray MG; Bradley J; Yang XF; Wimmer E; Moss EG; Racaniello VR
    Science; 1988 Jul; 241(4862):213-5. PubMed ID: 2838906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice.
    Martin A; Wychowski C; Couderc T; Crainic R; Hogle J; Girard M
    EMBO J; 1988 Sep; 7(9):2839-47. PubMed ID: 2460345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.